-1227C>T polymorphism in the pleiotrophin gene promoter influences bone mineral density in postmenopausal women

Molecular Genetics and Metabolism

Volumn 103, Issue 1, 2011, Pages 76-80

  Mencej Bedrač, Simona ^a   Preželj, Janez ^b   Komadina, Radko ^c   Vindišar, Franc ^c   Marc, Janja ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^c General Hospital Celje   (Slovenia)

Author keywords

Bone; Hip fracture; Osteoporosis; PTN; SNP

Indexed keywords

PLEIOTROPHIN;

ADULT; AGED; ARTICLE; BONE DENSITY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; HIP FRACTURE; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; PROMOTER REGION;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; BONE DENSITY; CARRIER PROTEINS; CYTOKINES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMENOPAUSE; PROMOTER REGIONS, GENETIC;

EID: 79955153086     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2011.01.017     Document Type: Article

References (33)

1. Ralston S.H., Crombrugghe B. Genetic regulation of bone mass and susceptibility to osteoporosis. Genes Dev. 2006, 20:2492-2506.
2. Farber C.R., Lusis A.J. Future of osteoporosis genetics: enhancing genome-wide association studies. J. Bone Miner. Res. 2009, 24:1937-1942.
3. Richards J.B., Rivadeneira F., Inouye M., Pastinen T.M., Soranzo N., Wilson S.G., Andrew T., Falchi M., Gwilliam R., Ahmadi K.R., Valdes A.M., Arp P., Whittaker P., Verlaan D.J., Jhamai M., Kumanduri V., Moorhouse M., van Meurs J.B., Hofman A., Pols H.A., Hart D., Zhai G., Kato B.S., Mullin B.H., Zhang F., Deloukas P., Uitterlinden A.G., Spector T.D. Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet 2008, 371:1505-1512.
4. Styrkarsdottir U., Halldorsson B.V., Gretarsdottir S., Gudbjartsson D.F., Walters G.B., Ingvarsson T., Jonsdottir T., Saemundsdottir J., Center J.R., Nguyen T.V., Bagger Y., Gulcher J.R., Eisman J.A., Christiansen C., Sigurdsson G., Kong A., Thorsteinsdottir U., Stefansson K. Multiple genetic loci for bone mineral density and fractures. N. Engl. J. Med. 2008, 358:2355-2365.
5. Rivadeneira F., Styrkársdottir U., Estrada K., Halldórsson B.V., Hsu Y.H., Richards J.B., Zillikens M.C., Kavvoura F.K., Amin N., Aulchenko Y.S., Cupples L.A., Deloukas P., Demissie S., Grundberg E., Hofman A., Kong A., Karasik D., van Meurs J.B., Oostra B., Pastinen T., Pols H.A., Sigurdsson G., Soranzo N., Thorleifsson G., Thorsteinsdottir U., Williams F.M., Wilson S.G., Zhou Y., Ralston S.H., van Duijn C.M., Spector T., Kiel D.P., Stefansson K., Ioannidis J.P., Uitterlinden A.G. Genetic Factors for Osteoporosis (GEFOS) Consortium, twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat. Genet. 2009, 41:1199-1206.
6. Hopwood B., Tsykin A., Findlay D.M., Fazzalari N.L. Gene expression profile of the bone microenvironment in human fragility fracture bone. Bone 2009, 44:87-101.
7. Trošt Z., Trebše R., Preželj J., Komadina R., Bitenc-Logar D., Marc J. A microarray based identification of osteoporosis-related genes in primary culture of human osteoblasts. Bone 2010, 46:72-80.
8. Deuel T.F., Zhang N., Yeh H.J., Silos-Santiago I., Wang Z.Y. Pleiotrophin: a cytokine with diverse functions and a novel signalling pathway. Arch. Biochem. Biophys. 2002, 397:162-171.
9. Zhou H.Y., Ohnuma Y., Takita H., Fujisawa R., Mizuno M., Kuboki Y. Effects of a bone lysine-rich 18kDa protein on osteoblast-like MC3T3-E1 cells. Biochem. Biophys. Res. Commun. 1992, 186:1288-1293.
10. Imai S., Heino T.J., Hienola A., Kurata K., Büki K., Matsusue Y., Väänänen H.K., Rauvala H. Osteocyte-derived HB-GAM (pleiotrophin) is associated with bone formation and mechanical loading. Bone 2009, 44:785-794.
11. Lehmann W., Schinke T., Schilling A.F., Catala-Lehnen P., Gebauer M., Pogoda P., Gerstenfeld L.C., Rueger J.M., Einhorn T.A., Amling M. Absence of mouse pleiotrophin does not affect bone formantion in vivo. Bone 2004, 35:1247-1255.
12. Tare R.S., Oreffo R.O., Sato K., Rauvala H., Clarke N.M., Roach H.I. Effects of targeted overexpression of pleiotrophin on postnatal bone development. Biochem. Biophys. Res. Commun. 2002, 298:324-332.
13. Li G., Bunn J.R., Mushipe M.T., He Q., Chen X. Effects of pleiotrophin (PTN) over-expression on mouse long bone development, fracture healing and bone repair. Calcif. Tissue Int. 2005, 76:299-306.
14. Xing W., Baylink D., Kesavan C., Hu Y., Kapoor S., Chadwick R.B., Mohan S. Global gene expression analysis in the bones reveals involvement of several novel genes and pathways in mediating an anabolic response of mechanical loading in mice. J. Cell. Biochem. 2005, 96:1049-1060.
15. Kesavan C., Mohan S. Lack of anabolic response to skeletal loading in mice with targeted disruption of the pleiotrophin gene. BMC Res. Notes 2008, 1:124.
16. Liedert A., Augat P., Ignatius A., Hausser H.J., Claes L. Mechanical regulation of HB-GAM expression in bone cells. Biochem. Biophys. Res. Commun. 2004, 319:951-958.
17. Gu D., Yu B., Zhao C., Ye W., Lv Q., Hua Z., Ma J., Zhang Y. The effect of pleiotrophin signalling on adipogenesis. FEBS Lett. 2007, 581:382-388.
18. World Health Organisation Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO study group. World Health Organ. Tech. Rep. Ser. 1994, 843:1-129.
19. The International HapMap Consortium A haplotype map of the human genome. Nature 2005, 437:1299-1320.
20. EMLD software accessed: May 2010. http://epi.mdanderson.org/~qhuang/Software/pub.htm.
21. Stephens M., Smith N.J., Donnelly P. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 2001, 68:978-989.
22. Stewart T.L., Jin H., McGuigan F.E.A., Albagha O.M.E., Garcia-Giralt N., Bassiti A., Grinberg D., Balcells S., Reid D.M., Ralston S.H. Haplotypes defined by promoter and intron 1 polymorphisms of the COLIA1 gene regulate bone mineral density in women. J. Clin. Endocrinol. Metab. 2006, 91:3575-3583.
23. *Power 3: a flexible statistical power analysis program for social, behavioral, and biomedical sciences. Behav. Res. Meth. 2007, 39:175-191.
24. Heinemeyer T., Wingender E., Reuter I., Hermjakob H., Kel A.E., Kel O.V., Ignatieva E.V., Ananko E.A., Podkolodnaya O.A., Kolpakov F.A., Podkolodny N.L., Kolchanov N.A. Databases on transcriptional regulation: TRANSFAC, TRRD, and COMPEL. Nucleic Acids Res. 1998, 26:364-370.
25. Garver R.I., Radford D.M., Donis-Keller H., Wick M.R., Milner P.G. Midkine and pleiotrophin expression in normal and malignant breast tissue. Cancer 1994, 74:1584-1590.
26. Garver R.I., Chan C.S., Milner P.G. Reciprocal expression of pleiotrophin and midkine versus malignant lung tissues. Am. J. Respir. Cell Mol. Biol. 1993, 9:463-466.
27. Kadomatsu K., Muramatsu T. Midkine and pleiotrophin in neural development and cancer. Cancer Lett. 2004, 204:127-143.
28. Herradon G., Ezquerra L., Gramage E., Alguacil L.F. Targeting the pleiotrophin/receptor protein tyrosine phosphatase beta/zeta signaling pathway to limit neurotoxicity induced by drug abuse. Mini Rev. Med. Chem. 2009, 9:440-447.
29. Perez-Pinera P., Berenson J.R., Deuel T.F. Pleiotrophin, a multifunctional angiogenic factor: mechanisms and pathways in normal and pathological angigenesis. Curr. Opin. Hematol. 2008, 15:210-214.
30. Mentlein R. Targeting pleiotrophin to treat osteoarthritis. Expert Opin. Ther. Targets 2007, 11:861-867.
31. Roccisana J.L., Kawanabe N., Kajiya H., Koide M., Roodman G.D., Reddy S.V. Functional role for heat shock factors in the transcriptional regulation of human RANK ligand expression in stromal/ osteoblast cells. J. Biol. Chem. 2004, 12:10500-10507.
32. Wong B.R., Josien R., Lee S.Y., Vologodskaia M., Steinman R.M., Choi Y. The TRAF family of signal transducers mediates NF-kB activation by the TRANCE Receptor. J. Biol. Chem. 1998, 273:28355-28359.
33. Grigoriadis A.E., Wang Z.Q., Cecchini M.G., Hofstetter W., Felix R., Fleisch H.A., Wagner E.F. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodelling. Science 1994, 266:443-448.